Showing results (2161-2170 of 3,162) with videos related to

Sort By:
Pageof 317
Diagnostic Microbiology and Infectious Disease|March 15, 2001
Carbapenem-resistant Serratia marcescens isolates producing Bush group 2f beta-lactamase (SME-1) in the United States: results from the MYSTIC ProgrammeA C Gales, D J Biedenbach, P Winokur, et al.
Journal of Clinical Microbiology|January 27, 2012
Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrataM A Pfaller, M Castanheira, S R Lockhart, et al.
International Journal of Antimicrobial Agents|February 7, 2012
Activity of JNJ-Q2, a new fluoroquinolone, tested against contemporary pathogens isolated from patients with community-acquired bacterial pneumoniaDouglas J Biedenbach, David J Farrell, Robert K Flamm, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2012
Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs)Helio S Sader, Susanne Paukner, Zrinka Ivezic-Schoenfeld, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 20, 2011
Vitamin D and calcium levels in Ugandan adults with human immunodeficiency virus and tuberculosisD Nansera, F M Graziano, D J Friedman, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 22, 2002
Antimicrobial susceptibility of bacteria causing urinary tract infections in Latin American hospitals: results from the SENTRY Antimicrobial Surveillance Program (1997)Helio S. Sader, Ronald N. Jones, Patricia L. Winokur, et al.
The Journal of Antibiotics|December 1, 1977
Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitinR N Jones, C Thornsberry, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1984
Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acidA L Barry, R N Jones, C Thornsberry, et al.
European Journal of Clinical Microbiology|December 1, 1984
3-0-demethyl fortimicin A: in vitro activity and interpretive zone standards for disk diffusion susceptibility testsA L Barry, R N Jones, C Thornsberry, et al.
International Journal of Antimicrobial Agents|March 10, 2010
Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolatesDavid J Farrell, Helio S Sader, Mariana Castanheira, et al.
Pageof 317